Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
$120,000.00
$120,000.00
$120,000.00
$120,000.00
N/A0.01N/AN/A
TRxADE HEALTH, Inc. stock logo
MEDS
TRxADE HEALTH
$6.50
-2.4%
$12.38
$3.69
$44.56
$7.87M2353,177 shs9,411 shs
PetIQ, Inc. stock logo
PETQ
PetIQ
$16.60
+0.5%
$17.39
$11.26
$22.98
$488.54M1.64284,741 shs207,168 shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
0.00%0.00%0.00%0.00%0.00%
TRxADE HEALTH, Inc. stock logo
MEDS
TRxADE HEALTH
-2.40%-7.93%-73.00%+52.94%+35.84%
PetIQ, Inc. stock logo
PETQ
PetIQ
+0.55%+2.47%-5.03%-8.99%+41.16%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/AN/AN/AN/AN/A
TRxADE HEALTH, Inc. stock logo
MEDS
TRxADE HEALTH
N/AN/AN/AN/AN/AN/AN/AN/A
PetIQ, Inc. stock logo
PETQ
PetIQ
3.1851 of 5 stars
3.53.00.00.02.61.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/A
TRxADE HEALTH, Inc. stock logo
MEDS
TRxADE HEALTH
N/AN/AN/AN/A
PetIQ, Inc. stock logo
PETQ
PetIQ
3.00
Buy$29.0074.70% Upside

Current Analyst Ratings

Latest PETQ, BTCA, and MEDS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/19/2024
PetIQ, Inc. stock logo
PETQ
PetIQ
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$24.00 ➝ $28.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/AN/AN/A
TRxADE HEALTH, Inc. stock logo
MEDS
TRxADE HEALTH
$11.45M0.69N/AN/A$0.55 per share11.82
PetIQ, Inc. stock logo
PETQ
PetIQ
$1.10B0.44$2.73 per share6.07$7.58 per share2.19

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/A0.00N/AN/AN/AN/AN/A
TRxADE HEALTH, Inc. stock logo
MEDS
TRxADE HEALTH
-$3.47M-$6.94N/AN/A-78.18%-69.22%-23.52%5/20/2024 (Estimated)
PetIQ, Inc. stock logo
PETQ
PetIQ
$2.13M$0.06276.7113.61N/A0.19%11.72%3.10%5/8/2024 (Confirmed)

Latest PETQ, BTCA, and MEDS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
PetIQ, Inc. stock logo
PETQ
PetIQ
$0.4180N/A-$0.4180N/AN/AN/A  
2/28/2024Q4 2023
PetIQ, Inc. stock logo
PETQ
PetIQ
-$0.38-$0.16+$0.22$0.28$189.70 million$219.93 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/AN/AN/A
TRxADE HEALTH, Inc. stock logo
MEDS
TRxADE HEALTH
N/AN/AN/AN/AN/A
PetIQ, Inc. stock logo
PETQ
PetIQ
N/AN/AN/AN/AN/A

Latest PETQ, BTCA, and MEDS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/28/2024
TRxADE HEALTH, Inc. stock logo
MEDS
TRxADE HEALTH
$8.003/25/20243/18/20243/22/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/AN/AN/A
TRxADE HEALTH, Inc. stock logo
MEDS
TRxADE HEALTH
N/A
0.61
0.28
PetIQ, Inc. stock logo
PETQ
PetIQ
1.97
2.27
1.43

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
N/A
TRxADE HEALTH, Inc. stock logo
MEDS
TRxADE HEALTH
5.68%
PetIQ, Inc. stock logo
PETQ
PetIQ
94.99%

Insider Ownership

CompanyInsider Ownership
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
41.40%
TRxADE HEALTH, Inc. stock logo
MEDS
TRxADE HEALTH
48.40%
PetIQ, Inc. stock logo
PETQ
PetIQ
9.30%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bactolac Pharmaceutical Inc stock logo
BTCA
Bactolac Pharmaceutical
126N/AN/ANot Optionable
TRxADE HEALTH, Inc. stock logo
MEDS
TRxADE HEALTH
331.21 million622,000Not Optionable
PetIQ, Inc. stock logo
PETQ
PetIQ
1,93329.43 million26.69 millionOptionable

PETQ, BTCA, and MEDS Headlines

SourceHeadline
PetIQ, Inc. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024PetIQ, Inc. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
globenewswire.com - April 22 at 4:15 PM
Unleash Your Portfolio: 3 Pet Stocks Poised to Fetch Big ReturnsUnleash Your Portfolio: 3 Pet Stocks Poised to Fetch Big Returns
investorplace.com - April 18 at 6:30 AM
Wall Street Analysts Think PetIQ (PETQ) Could Surge 76.18%: Read This Before Placing a BetWall Street Analysts Think PetIQ (PETQ) Could Surge 76.18%: Read This Before Placing a Bet
zacks.com - April 15 at 10:55 AM
White Brook Capital Partners Q1 2024 CommentaryWhite Brook Capital Partners Q1 2024 Commentary
seekingalpha.com - April 13 at 1:07 PM
Vanguard Group Inc. Buys 226,718 Shares of PetIQ, Inc. (NASDAQ:PETQ)Vanguard Group Inc. Buys 226,718 Shares of PetIQ, Inc. (NASDAQ:PETQ)
marketbeat.com - April 11 at 4:11 AM
PetIQ, Inc. (PETQ) Is a Trending Stock: Facts to Know Before Betting on ItPetIQ, Inc. (PETQ) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com - April 10 at 10:00 AM
Theres Been No Shortage Of Growth Recently For PetIQs (NASDAQ:PETQ) Returns On CapitalThere's Been No Shortage Of Growth Recently For PetIQ's (NASDAQ:PETQ) Returns On Capital
finance.yahoo.com - April 9 at 6:11 PM
PetIQ (PETQ) Dips More Than Broader Market: What You Should KnowPetIQ (PETQ) Dips More Than Broader Market: What You Should Know
finance.yahoo.com - April 8 at 8:55 PM
Should Value Investors Buy PetIQ (PETQ) Stock?Should Value Investors Buy PetIQ (PETQ) Stock?
zacks.com - April 8 at 10:46 AM
Assenagon Asset Management S.A. Decreases Stake in PetIQ, Inc. (NASDAQ:PETQ)Assenagon Asset Management S.A. Decreases Stake in PetIQ, Inc. (NASDAQ:PETQ)
marketbeat.com - March 31 at 4:42 AM
Wall Street Analysts Believe PetIQ (PETQ) Could Rally 58.64%: Heres is How to TradeWall Street Analysts Believe PetIQ (PETQ) Could Rally 58.64%: Here's is How to Trade
zacks.com - March 29 at 10:56 AM
Are Investors Undervaluing PetIQ (PETQ) Right Now?Are Investors Undervaluing PetIQ (PETQ) Right Now?
zacks.com - March 21 at 10:46 AM
PetIQ (PETQ) Broadens Minties Line With Large Dogs Dental TreatsPetIQ (PETQ) Broadens Minties Line With Large Dogs Dental Treats
zacks.com - March 18 at 10:31 AM
PetIQ, Inc. Celebrates Expansion of Minties® Dental Treats Brand With Launch of New Dental Chew for Large-Sized DogsPetIQ, Inc. Celebrates Expansion of Minties® Dental Treats Brand With Launch of New Dental Chew for Large-Sized Dogs
globenewswire.com - March 14 at 9:00 AM
PetIQ, Inc. Kicks Off Flea & Tick Season With NextStar® Campaign Introducing New Pet Parent Education and Veterinary Support ResourcesPetIQ, Inc. Kicks Off Flea & Tick Season With NextStar® Campaign Introducing New Pet Parent Education and Veterinary Support Resources
globenewswire.com - March 7 at 10:00 AM
PetIQ Full Year 2023 Earnings: EPS: US$0.073 (vs US$1.65 loss in FY 2022)PetIQ Full Year 2023 Earnings: EPS: US$0.073 (vs US$1.65 loss in FY 2022)
finance.yahoo.com - March 1 at 10:44 AM
PetIQ, Inc. (NASDAQ:PETQ) Q4 2023 Earnings Call TranscriptPetIQ, Inc. (NASDAQ:PETQ) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 29 at 1:30 PM
PetIQ, Inc. 2023 Q4 - Results - Earnings Call PresentationPetIQ, Inc. 2023 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 29 at 12:07 AM
Heres what to expect from PetIQ As earningsHere's what to expect from PetIQ A's earnings
markets.businessinsider.com - February 28 at 8:51 PM
PetIQ: Q4 Earnings SnapshotPetIQ: Q4 Earnings Snapshot
sfgate.com - February 28 at 8:51 PM
PetIQ Inc (PETQ) Reports Strong Growth in 2023 with Record Net Sales and Cash FlowPetIQ Inc (PETQ) Reports Strong Growth in 2023 with Record Net Sales and Cash Flow
finance.yahoo.com - February 28 at 8:51 PM
PetIQ (PETQ) Reports Q4 Loss, Tops Revenue EstimatesPetIQ (PETQ) Reports Q4 Loss, Tops Revenue Estimates
zacks.com - February 28 at 7:01 PM
PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsPetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
globenewswire.com - February 28 at 4:05 PM
PETQ Jul 2024 17.500 putPETQ Jul 2024 17.500 put
finance.yahoo.com - February 26 at 11:38 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bactolac Pharmaceutical logo

Bactolac Pharmaceutical

OTCMKTS:BTCA
Bactolac Pharmaceutical, Inc. engages in the research, development and commercialization of vitamins and neutraceuticals. It offers nutritional supplements and shake powders, resveratrol, probiotics, multivitamins, antioxidant products, sports and hormone supplements, and weight loss and detoxification drugs. The company was founded by Pailla Malla Reddy in 1995 and is headquartered in Hauppauge, NY.
TRxADE HEALTH logo

TRxADE HEALTH

NASDAQ:MEDS
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.
PetIQ logo

PetIQ

NASDAQ:PETQ
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.